Hengeler Mueller advises banks on EUR 10 bn. EMTN program and EUR 500 m. bond by Fresenius Medical Care
31. July 2018
Fresenius Medical Care AG & Co. KGaA, one of the world’s largest providers of dialysis products and services, successfully placed notes with an aggregate principal amount of EUR 500 million. The notes have a maturity of 7 years and an annual coupon of 1.5% and will be guaranteed by a US subsidiary of the issuer. The proceeds will be used for general corporate purposes, including the refinancing of upcoming maturities. The notes were drawn under the newly established European Medium Term Note (EMTN) program by Fresenius Medical AG & Co. KGaA. The program allows for standardized issuances of notes in various currencies and maturities.
Hengeler Mueller has advised the banks on the transaction. The Hengeler Mueller team included partner Hendrik Haag as well as associates Jochen Schnepper and Henrik Gildehaus (all capital markets, Frankfurt).